Jaleh Barar* 
|
Yadollah Omidi*
|
Ailar Nakhlband, Yadollah Omidi*
|
Yadollah Omidi* , Jaleh Barar
|
Jaleh Barar , Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi*
|
Jaleh Barar , Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi*
|
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi , Nazli Saeedi, Samad Ghafari, Jaleh Barar* , Alireza Garjani*
|
Marziyeh Fathi , Azam Safary , Jaleh Barar*
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.
|
Wael A. Mahdi , Mohammad S. Absar, Suna Choi, Victor C. Yang, Young M. Kwon*
The tPA was successfully modified via enzymatic oxidation by GO, resulting in enhanced control of its activity in the prodrug construct. This approach can be applied to other therapeutic glycoproteins.
|
Forough Shams , Hamideh Moravvej , Simzar Hosseinzadeh, Bahram Kazemi, Masoumrh Rajabibazl, Azam Rahimpour*
The present results highlight the potential of reporter gene targeting for the in vitro analysis of biological processes such as migration.
|
Behnaz Babaye Abdollahi , Marjan Ghorbani, Hamed Hamishehkar, Reza Malekzadeh, Alireza Farajollahi*
This study shows the positive effect of synthesized Trastuzumab loaded PEG-Fe3O4@Au nanoparticleson increasing the death rate of Breast cancer cells during megavoltage radiation therapy.
|
Mostafa Akbarzadeh-Khiavi , Azam Safary , Yadollah Omidi*
|